{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Xu L"],"pubmed_abstract":["<h4>Background</h4>Posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) comorbidity occurs through exposure to trauma with genetic susceptibility. Neuropeptide-Y (NPY) and dopamine are neurotransmitters associated with anxiety and stress-related psychiatry through receptors. We attempted to explore the genetic association between two neurotransmitter receptor systems and the PTSD-MDD comorbidity.<h4>Methods</h4>Four groups were identified using latent profile analysis (LPA) to examine the patterns of PTSD and MDD comorbidity among survivors exposed to earthquake-related trauma: low symptoms, predominantly depression, predominantly PTSD, and PTSD-MDD comorbidity. <i>NPY2R</i> (rs4425326), <i>NPY5R</i> (rs11724320), <i>DRD2</i> (rs1079597), and <i>DRD3</i> (rs6280) were genotyped from 1,140 Chinese participants exposed to earthquake-related trauma. Main, gene-environment interaction (G × E), and gene-gene interaction (G × G) effects for low symptoms, predominantly depression, and predominantly PTSD were tested using a multinomial logistic model with PTSD-MDD comorbidity as a reference.<h4>Results</h4>The results demonstrated that compared to PTSD-MDD comorbidity, epistasis (G × G) <i>NPY2R</i>-<i>DRD2</i> (rs4425326 × rs1079597) affects low symptoms (<i>β</i> = -0.66, <i>OR</i> = 0.52 [95% CI: 0.32-0.84], <i>p</i> = 0.008, <i>p<sub>perm</sub></i> = 0.008) and predominantly PTSD (<i>β</i> = -0.56, <i>OR</i> = 0.57 [95% CI: 0.34-0.97], <i>p</i> = 0.037, <i>p<sub>perm</sub></i> = 0.039), while <i>NPY2R</i>-<i>DRD3</i> (rs4425326 × rs6280) impacts low symptoms (<i>β</i> = 0.82, <i>OR</i> = 2.27 [95% CI: 1.26-4.10], <i>p</i> = 0.006, <i>p<sub>perm</sub></i> = 0.005) and predominantly depression (<i>β</i> = 1.08, <i>R</i> = 2.95 [95% CI: 1.55-5.62], <i>p</i> = 0.001, <i>p<sub>perm</sub></i> = 0.001). The two G × G effects are independent.<h4>Conclusion</h4>NPY and dopamine receptor genes are related to the genetic etiology of PTSD-MDD comorbidity, whose specific mechanisms can be studied at multiple levels."],"journal":["Frontiers in psychiatry"],"pagination":["1257911"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937445"],"repository":["biostudies-literature"],"pubmed_title":["Epistasis in neurotransmitter receptors linked to posttraumatic stress disorder and major depressive disorder comorbidity in traumatized Chinese."],"pmcid":["PMC10937445"],"pubmed_authors":["Xu L","Yang H","Zhang K","Zhang J","Wang B","Liu P","Cao C","Fang R","Luo S","Wang L"],"additional_accession":[]},"is_claimable":false,"name":"Epistasis in neurotransmitter receptors linked to posttraumatic stress disorder and major depressive disorder comorbidity in traumatized Chinese.","description":"<h4>Background</h4>Posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) comorbidity occurs through exposure to trauma with genetic susceptibility. Neuropeptide-Y (NPY) and dopamine are neurotransmitters associated with anxiety and stress-related psychiatry through receptors. We attempted to explore the genetic association between two neurotransmitter receptor systems and the PTSD-MDD comorbidity.<h4>Methods</h4>Four groups were identified using latent profile analysis (LPA) to examine the patterns of PTSD and MDD comorbidity among survivors exposed to earthquake-related trauma: low symptoms, predominantly depression, predominantly PTSD, and PTSD-MDD comorbidity. <i>NPY2R</i> (rs4425326), <i>NPY5R</i> (rs11724320), <i>DRD2</i> (rs1079597), and <i>DRD3</i> (rs6280) were genotyped from 1,140 Chinese participants exposed to earthquake-related trauma. Main, gene-environment interaction (G × E), and gene-gene interaction (G × G) effects for low symptoms, predominantly depression, and predominantly PTSD were tested using a multinomial logistic model with PTSD-MDD comorbidity as a reference.<h4>Results</h4>The results demonstrated that compared to PTSD-MDD comorbidity, epistasis (G × G) <i>NPY2R</i>-<i>DRD2</i> (rs4425326 × rs1079597) affects low symptoms (<i>β</i> = -0.66, <i>OR</i> = 0.52 [95% CI: 0.32-0.84], <i>p</i> = 0.008, <i>p<sub>perm</sub></i> = 0.008) and predominantly PTSD (<i>β</i> = -0.56, <i>OR</i> = 0.57 [95% CI: 0.34-0.97], <i>p</i> = 0.037, <i>p<sub>perm</sub></i> = 0.039), while <i>NPY2R</i>-<i>DRD3</i> (rs4425326 × rs6280) impacts low symptoms (<i>β</i> = 0.82, <i>OR</i> = 2.27 [95% CI: 1.26-4.10], <i>p</i> = 0.006, <i>p<sub>perm</sub></i> = 0.005) and predominantly depression (<i>β</i> = 1.08, <i>R</i> = 2.95 [95% CI: 1.55-5.62], <i>p</i> = 0.001, <i>p<sub>perm</sub></i> = 0.001). The two G × G effects are independent.<h4>Conclusion</h4>NPY and dopamine receptor genes are related to the genetic etiology of PTSD-MDD comorbidity, whose specific mechanisms can be studied at multiple levels.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-07-01T03:22:15.962Z","creation":"2026-07-01T03:07:46.366Z"},"accession":"S-EPMC10937445","cross_references":{"pubmed":["38487579"],"doi":["10.3389/fpsyt.2024.1257911"]}}